RafiKabarritiMD

Radiation Oncology • Bronx, NY

Physician

Join to view full profile

Dr. Kabarriti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kabarriti's full profile

Already have an account?

Office
111 E 210th St
Bronx, NY 10467
Phone+1 718-920-7750

Education & Training

Albert Einstein College of MedicineClass of 2010

Certifications & Licensure

NY State Medical License 2015 - 2026
American Board of Radiology Radiation Oncology

Clinical Trials

Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) Start of enrollment: 2022 Oct 06
Recruiting
Phase 3
Roles: Principal Investigator
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer Start of enrollment: 2022 Aug 09
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX) Start of enrollment: 2024 Jan 18
Recruiting
Phase 1
Roles: Principal Investigator

Publications & Presentations

PubMed

3 citations
Stereotactic radiosurgery with immunotherapy is associated with improved overall survival in patients with metastatic melanoma or non-small cell lung cancer: a Nationa...
J. Jiang, Rafi Kabarriti, N.P. Brodin, Nitin Ohri, Chandan Guha
Clinical & Translational Oncology. 2021-07-08
11 citations
PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiother...
Marcelo Bonomi, Dukagjin M Blakaj, Rafi Kabarriti, Kyle Colvett, Vinita Takiar
International Journal of Radiation Oncology, Biology, Physics. 2023-07-01
8 citations
Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer.
N. Patrik Brodin, Rafi Kabarriti, Clyde B. Schechter, M. Pankuch, Vinai Gondi
Radiation Oncology. 2021-01-21

Journal Articles

Radiation Therapy for Patients with Newly Diagnosed Metastatic Head and Neck Squamous Cell Carcinoma
Rafi Kabarriti, Nitin Ohri, Chandan Guha, Madhur K Garg, Sujith Baliga, Shalom Kalnicki, Head & Neck
Utilization of Transoral Robotic Surgery (TORS) in Patients with Oropharyngeal Squamous Cell Carcinoma and Its Impact on Survival and Use of Chemotherapy
Sujith Baliga, Julie Jiang, Chandan Guha, Rafi Kabarriti, Madhur K Garg, Shalom Kalnicki, Richard V Smith, Vikas Mehta, ScienceDirect

Lectures

Human papillomavirus, radiation dose and survival of patients with anal cancer.
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019

Press Mentions

No Race Difference Found in COVID-19 Mortality Rates at Same Medical CenterSeptember 30th, 2020
Un Estudio Determina La No Disparidad Racial Entre Las Tasas De Mortalidad en Casos De COVID-19 en Montefiore, Al Controlar Los Factores De Riesgo ClaveSeptember 25th, 2020
Cancer Patients Face High Mortality from COVID-19May 4th, 2020
Join now to see all